Latest Senzime News & Updates
See the latest news and media coverage for Senzime. We track all announcements, press releases, and industry mentions in real time, all in one place.
Precision-based patient monitoring solutions provider
senzime.com- Headquarters
- Uppsala, Sweden
- Founded year
- 1999
- Company type
- Public company
- Number of employees
- 60–200
Last updated
Latest news about Senzime
In short: Senzime achieved significant commercial expansion, securing major US hospital contracts and GPO listings while targeting 2026 profitability.
Company announcements
-
Senzime secures listings with three major US GPOs
The TetraGraph System is included in Vizient, Premier, and HealthTrust agreements, improving procurement access and shortening potential sales cycles.
-
Senzime publishes annual and sustainability report for 2025
The report highlights sales exceeding SEK 100 million, goal achievement, strategic wins, and profitability foundation for 2026. CEO Philip Siberg comments on growth.
-
Senzime reports strengthened margins and improved cash flow
Net sales dipped 1% to SEK 23.2M due to US delays, but full-year targets remain on track with profitability by year-end.
-
Senzime expands contract with US hospital system
The agreement adds 65 TetraGraph systems, bringing the total to over 160 and generating over SEK 6 million in annual recurring revenue.
Media coverage
-
Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the US
UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that the TetraGraph System has secured inclusion in...
-
Senzime Publishes Annual and Sustainability Report for 2025
UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) announces today that the company's annual and sustainability report...
-
Margins Strengthened and Cash Flow Improved Despite a Temporary Dip in The Growth Trajectory....
UPPSALA, SE / ACCESS Newswire / April 22, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2026 is...
-
Senzime's loss decreases slightly
The medical technology company Senzime reports an EBITDA result of -20.2 million kronor (-20.8) for the first quarter of 2026.
Track Senzime and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Senzime competitors & trending companies
Browse news for competitors to Senzime and other trending companies.
IDMED
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove